EverSource Wealth Advisors’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$174K Sell
1,619
-438
-21% -$28.7K 0.01% 1070
2026
Q1
$16.3K Buy
2,057
+953
+86% +$15.4K ﹤0.01% 2634
2025
Q4
$19K Buy
1,104
+859
+351% +$16.7K ﹤0.01% 2419
2025
Q3
$6.31K Sell
245
-26
-10% -$982 ﹤0.01% 3045
2025
Q2
$15.6K Buy
271
+252
+1,326% +$20.2K ﹤0.01% 2483
2025
Q1
$2.05K Buy
19
+14
+280% +$1.22K ﹤0.01% 2920
2024
Q4
$260 Buy
+5
New +$302 ﹤0.01% 3369
2022
Q1
Sell
-6
Closed -$4K 1694
2021
Q4
$4K Buy
+6
New +$3.65K ﹤0.01% 1300

Other funds holding AGL

EverSource Wealth Advisors's AGL Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Agilon Health (AGL) stake by 21% in Q2 2026, selling an estimated $28.7K and leaving 1,619 shares worth $174K. The position accounts for 0.01% of the portfolio, ranked #1070.

EverSource Wealth Advisors first reported a position in AGL in Q4 2021 and has held it in 8 quarters since. 43 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • EverSource Wealth Advisors held 1,619 shares of Agilon Health worth $174K as of Q2 2026.
  • EverSource Wealth Advisors sold 438 Agilon Health shares in Q2 2026, an estimated $28.7K.
  • Agilon Health made up 0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #1070 holding.
  • EverSource Wealth Advisors first reported a position in Agilon Health in Q4 2021 and has held it in 8 quarters since.
  • 43 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.